GI Chronic Care Risk Stratification Workflow Guide
Optimize GI patient outcomes with our chronic care risk stratification workflow for IBD, cirrhosis, and hepatology management using AI automation.
Effective risk stratification in gastroenterology is the cornerstone of managing high-acuity conditions like Crohn’s disease, ulcerative colitis, and advanced cirrhosis. By identifying high-risk patients early, GI practices can prioritize interventions, optimize APCM enrollment, and ensure biologic therapy compliance through automated AI-driven outreach and monitoring workflows.
Gastroenterology practices often struggle to identify high-risk IBD or liver patients buried in high-volume procedure schedules, leading to missed APCM revenue and delayed care for patients needing urgent biologic adjustments or cirrhosis management.
Step-by-Step Workflow
Data Mining for Chronic GI Indicators
Identify patients within your EHR using specific ICD-10 codes for IBD, chronic hepatitis, and cirrhosis. Use AI to scan clinical notes for mentions of frequent flares or PPI dependency.
- Focus on patients with multiple co-morbidities like GERD and NAFLD
- Filter by medication history, specifically those on long-term biologics
- Relying solely on procedure history instead of chronic diagnosis codes
AI-Driven Symptom Assessment Outreach
Deploy AI voice agents to conduct automated screenings for weight loss, jaundice, or increased bowel frequency. This gathers real-time data without taxing front-desk staff.
- Schedule calls during mid-morning for higher pick-up rates
- Use natural language processing to flag urgent symptoms like hematochezia
- Using overly technical medical jargon in automated voice prompts
Clinical Stratification by Disease Activity
Categorize patients into Low, Moderate, or High risk tiers based on standardized scores such as the Mayo Score for UC, CDAI for Crohn's, or MELD for liver disease.
- Automate the calculation of these scores through integrated AI tools
- Update risk tiers quarterly based on lab results and symptom reports
- Failing to account for mental health comorbidities in IBD patients
Biologic and Lab Monitoring Integration
Sync risk tiers with biologic infusion schedules. High-risk patients require more frequent therapeutic drug monitoring (TDM) and liver function tests to prevent decompensation.
- Set automated alerts for upcoming fecal calprotectin tests
- Track anti-drug antibody levels for patients on anti-TNF agents
- Missing lab windows due to manual tracking errors
APCM Enrollment and Consent Automation
Identify candidates eligible for Advanced Primary Care Management (APCM). Use AI to explain program benefits and capture verbal consent for chronic care billing.
- Target patients with 2+ chronic GI conditions for maximum APCM impact
- Ensure consent is documented directly into the EHR via AI integration
- Neglecting to mention the monthly cost-sharing aspect to patients
Personalized Care Plan Generation
Develop structured care plans focusing on nutrition, medication adherence, and emergency flare protocols. AI can help generate these plans based on the patient's risk profile.
- Include specific instructions for 'low-residue' diets during flares
- Provide clear triggers for when a patient should call the GI on-call line
- Creating generic care plans that don't address specific GI subtypes
Continuous Remote Monitoring and Feedback
Implement monthly AI check-ins to track bowel frequency and jaundice. Use this data to adjust risk stratification levels and schedule follow-up appointments proactively.
- Use AI to identify trends, such as a gradual increase in daily BM count
- Loop in the APCM coordinator when a patient moves from low to high risk
- Ignoring subtle symptom changes that precede a major GI flare
Expected Outcomes
Increased APCM enrollment rates for chronic GI and hepatology patients
Reduced emergency admissions for IBD flares and cirrhosis decompensation
Improved adherence to biologic therapy and lab monitoring schedules
Higher practice revenue through structured chronic care billing
Enhanced patient satisfaction via proactive AI-driven communication
Frequently Asked Questions
AI automates the collection of patient-reported outcomes (PROs) like bowel movement frequency and abdominal pain, allowing clinicians to focus on high-risk cases rather than manual data entry.
Yes, by systematically identifying and enrolling patients with two or more chronic conditions, such as GERD and fatty liver disease, you maximize billable care minutes and ensure compliance.
Regular monitoring ensures patients on biologics maintain therapeutic levels, reducing the risk of anti-drug antibody formation and subsequent disease flares, which keeps patients in lower risk tiers.
Ready to transform your gastroenterology practice?
See how Tile Healthcare's AI call center can handle scheduling, triage, and patient communication for your practice.
Schedule a Demo